Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence

Robert H. Eckel, Abby G. Ershow, Cheryl A.M. Anderson, Prakash Deedwania, Elizabeth Selvin, Ian H. de Boer, Michael Pignone, Robert G. Nelson, Silvio E. Inzucchi, Mikhail Kosiborod, Caroline S. Fox, Lora E. Burke, Judith Fradkin, Sherita Hill Golden, George A. Bray, Mahesh J. Patel, Laurie Quinn, Philip R. Schauer, Dorothea K. Vafiadis

2015-08-05

SCID: 54.1/yxjhtkku

Abstract (AI)

Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.

Key Findings

Research Object

Research Subject

Publication Details

DOI

10.1161/cir.0000000000000230

Publication Date

2015-08-05

Journal

Publisher

ISSN

Access Type

Author Information

Authors

Robert H. Eckel

Abby G. Ershow

Cheryl A.M. Anderson

Prakash Deedwania

Elizabeth Selvin

Ian H. de Boer

Michael Pignone

Robert G. Nelson

Silvio E. Inzucchi

Mikhail Kosiborod

Caroline S. Fox

Lora E. Burke

Judith Fradkin

Sherita Hill Golden

George A. Bray

Mahesh J. Patel

Laurie Quinn

Philip R. Schauer

Dorothea K. Vafiadis

Download PDF